‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study

Author:

Logeman CharlotteORCID,Cho Yeoungjee,Sautenet Benedicte,Rangan Gopala K,Gutman Talia,Craig Jonathan,Ong Albert,Chapman Arlene,Ahn CurieORCID,Coolican Helen,Tze-Wah Kao Juliana,Gansevoort Ron T,Perrone Ronald,Harris Tess,Torres Vincent,Fowler Kevin,Pei York,Kerr Peter,Ryan Jessica,Johnson David,Viecelli Andrea,Geneste Clair,Kim Hyunsuk,Kim Yaerim,Howell MartinORCID,Ju Angela,Manera Karine E,Teixeira-Pinto Armando,Parasivam Gayathri,Tong Allison

Abstract

Background and objectivesPresymptomatic testing is available for early diagnosis of hereditary autosomal dominant polycystic kidney disease (ADPKD). However, the complex ethical and psychosocial implications can make decision-making challenging and require an understanding of patients’ values, goals and priorities. This study aims to describe patient and caregiver beliefs and expectations regarding presymptomatic testing for ADPKD.Design, setting and participants154 participants (120 patients and 34 caregivers) aged 18 years and over from eight centres in Australia, France and Korea participated in 17 focus groups. Transcripts were analysed thematically.ResultsWe identified five themes: avoiding financial disadvantage (insecurity in the inability to obtain life insurance, limited work opportunities, financial burden); futility in uncertainty (erratic and diverse manifestations of disease limiting utility, taking preventive actions in vain, daunted by perplexity of results, unaware of risk of inheriting ADPKD); lacking autonomy and support in decisions (overwhelmed by ambiguous information, medicalising family planning, family pressures); seizing control of well-being (gaining confidence in early detection, allowing preparation for the future, reassurance in family resilience); and anticipating impact on quality of life (reassured by lack of symptoms, judging value of life with ADPKD).ConclusionsFor patients with ADPKD, presymptomatic testing provides an opportunity to take ownership of their health through family planning and preventive measures. However, these decisions can be wrought with tensions and uncertainty about prognostic implications, and the psychosocial and financial burden of testing. Healthcare professionals should focus on genetic counselling, mental health and providing education to patients’ families to support informed decision-making. Policymakers should consider the cost burden and risk of discrimination when informing government policies. Finally, patients are recommended to focus on self-care from an early age.

Funder

Polycystic Kidney Disease Foundation of Australia and the National Health and Medical Research Council

Research of Korea Center for Disease Control & Prevention

NHMRC Practitioner Fellowship

NHMRC Postgraduate Scholarship

Royal Australasian College of Physicians

NHMRC BEAT-CKD Program Grant

Polycystic Kidney Disease Foundation of Australia and the National Health and Medical Research Council and Better Evidence and Translation in Chronic Kidney Disease

NHMRC Early Career Fellowship

UMR INSERM 1246 – SPHERE methods in Patients-centered outcomes and Health Research

NHMRC Medical Postgraduate Scholarship

Publisher

BMJ

Subject

General Medicine

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3